| Brand Name | Curasia Medilabs |
|---|---|
| Industry / Business Category | Healthcare Products / Pharmaceutical PCD |
| Founded Year | 2019 |
| Franchise Started Year | 2019 |
| Total Franchise Outlets | 1,000–10,000 |
| Estimated Investment | INR 50,000 – 2 Lakh |
| Franchise Fee | Data not specified |
| Royalty Fee | Data not specified |
| Space Requirement | 100–200 sq.ft |
| Staff Requirement | Minimal; typically distributor and administrative support |
| Expected Payback Period | 1–2 years |
Curasia Medilabs is an Indian pharmaceutical company specializing in the manufacturing and distribution of healthcare products. The brand operates within the pharmaceutical and healthcare sector, offering allopathic and herbal formulations across therapeutic segments, including neuropsychiatric care. Its primary customers include pharmacies, distributors, healthcare professionals, and PCD franchise partners seeking pharmaceutical product portfolios.
Curasia Medilabs operates through a combination of direct product manufacturing, PCD franchise distribution, and third-party contract manufacturing. Customers engage via pharmacies, clinics, and healthcare providers. Revenue is generated from the sale of pharmaceutical products, distribution rights granted to franchise partners, and manufacturing contracts. Daily operations involve production, quality control, inventory management, and distribution logistics.
| Neuropsychiatric Care Products | Treatments for disorders such as anxiety, depression, epilepsy, and Alzheimer’s disease under the Curasia Neurocare division |
|---|---|
| Allopathic Formulations | Tablets, capsules, syrups, injectables, and ointments |
| Herbal and Nutraceutical Products | Plant-based and therapeutic formulations |
| Third-Party Manufacturing Services | Custom product manufacturing for other brands including formulation, packaging, and regulatory compliance |
| Franchise Partner Role | Operates distribution channels within a designated territory, promoting and selling Curasia Medilabs’ products |
|---|---|
| Responsibilities of Franchise Owner | Establish client network, manage inventory, and ensure product compliance |
| Outlet Operation | Franchisees function primarily as distributors with minimal physical space and staff requirements |
| Franchisor Support | Curasia provides marketing materials, product training, promotional strategies, and technical guidance |
| Estimated Investment | INR 50,000 – 2 Lakh, depending on territory and initial stock |
|---|---|
| Franchise Fee | Not specified |
| Setup Costs | Initial inventory procurement, marketing materials, basic office setup |
| Royalty / Ongoing Fees | Not specified |
| Space Requirement | 100–200 sq.ft |
|---|---|
| Preferred Location | Accessible office or distribution space suitable for storage and administrative operations |
| Equipment / Infrastructure Needs | Basic storage racks, computers for order management, and communication tools |
| Staffing Requirements | Typically minimal; one or two personnel for operations and distribution |
| Revenue Sources | Sale of pharmaceutical products through franchise distribution |
|---|---|
| Customer Demand | Driven by healthcare professionals, pharmacies, and end-user demand for therapeutic products |
| Repeat Purchase Potential | Recurring orders from distributors and pharmacies |
| Operational Cost Considerations | Primarily inventory, storage, and minimal administrative expenses |
| Expected Payback Period | 1–2 years |
| Established Year | 2019 |
|---|---|
| Franchise Commencement | 2019 |
| Current Network | 1,000–10,000 franchise outlets across India |
| Geographic Markets Served | Nationwide |
| Expansion Plans | Increase distribution network and grow franchise presence in emerging markets within India |
| Estimated Investment | INR 50,000 – 2 Lakh |
|---|---|
| Franchise Fee | Data not specified |
| Space Requirement | 100–200 sq.ft |
| Brand Support | Marketing and sales guidance, product training |
| Royalty Structure | Not specified |
| Expected Payback Period | 1–2 years |
| Existing Franchise Outlets | 1,000–10,000 |
Curasia Medilabs offers a structured pharmaceutical PCD franchise model with a broad product range, low entry investment, and support in marketing and distribution. The opportunity suits entrepreneurs interested in healthcare distribution with scalable growth potential.
A: The investment ranges from INR 50,000 to 2 Lakh, covering initial inventory, marketing, and basic setup costs.
A: Franchisees operate distribution channels, promote pharmaceutical products, manage inventory, and receive support from the company for marketing and sales.
A: Franchise operations require 100–200 sq.ft, sufficient for storage and administrative tasks.
A: The payback period typically ranges from 1–2 years, depending on sales performance and market demand.
A: Interested investors can contact Curasia Medilabs directly to discuss territory allocation, review product portfolios, and complete franchise agreements. ## Similar Franchise Opportunities